Humer Kristian — SEC Form 4 filings

SEC reporting owner CIK 1872280. 6 Form 4 filings on record with FilingPulse; latest filed 2025-12-11.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2024-04-17 to 2025-12-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Foghorn Therapeutics Inc. (FHTX)Chief Financial Officer32
Sensei Biotherapeutics, Inc. (SNSE)Director22
4D Molecular Therapeutics, Inc. (FDMT)Chief Financial Officer11

Form 4 filings — Humer Kristian

FiledFormIssuerReported transactionsSource
2025-12-1144D Molecular Therapeutics, Inc. (FDMT)Grant/award (A): 480,000 (derivative) @ $0EDGAR
2025-11-174Foghorn Therapeutics Inc. (FHTX)Holdings only — no transactions reportedEDGAR
2025-05-234Sensei Biotherapeutics, Inc. (SNSE)Grant/award (A): 19,000 (derivative) @ $0EDGAR
2025-01-244Foghorn Therapeutics Inc. (FHTX)Grant/award (A): 120,000 (derivative) @ $4.37EDGAR
2024-06-134Sensei Biotherapeutics, Inc. (SNSE)Grant/award (A): 19,000 (derivative) @ $0EDGAR
2024-04-174Foghorn Therapeutics Inc. (FHTX)Grant/award (A): 275,000 (derivative) @ $6.03EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1872280 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →